Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gernot Zollner

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Digestive Diseases (Basel, Switzerland)|June 22, 2011
Targeting nuclear bile acid receptors for liver diseaseMichael Trauner, Anna Baghdasaryan, Thierry Claudel, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 23, 2018
Bile acids and glucocorticoid metabolism in health and diseaseVerena Theiler-Schwetz, Alex Zaufel, Hansjörg Schlager, et al.
Digestive Diseases (Basel, Switzerland)|June 22, 2011
Ursodeoxycholic acid for treatment of fatty liver disease and dyslipidemia in morbidly obese patientsHanns-Ulrich Marschall, Martin Wagner, Gernot Zollner, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 26, 2001
Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated miceGernot Zollner, Peter Fickert, Dagmar Silbert, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2007
Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosisGernot Zollner, Martin Wagner, Peter Fickert, et al.
Digestive Diseases (Basel, Switzerland)|May 13, 2010
New insights into autoimmune cholangitis through animal modelsMichael Trauner, Peter Fickert, Anna Baghdasaryan, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 22, 2017
Genetic loss of the muscarinic M<sub>3</sub> receptor markedly alters bile formation and cholestatic liver injury in miceFranziska Durchschein, Elisabeth Krones, Marion J Pollheimer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 23, 2005
Hepatobiliary transporter expression in human hepatocellular carcinomaGernot Zollner, Martin Wagner, Peter Fickert, et al.
BMC Gastroenterology|December 8, 2021
Hypercortisolism in patients with cholestasis is associated with disease severityVerena Theiler-Schwetz, Hansjörg Schlager, Barbara Obermayer-Pietsch, et al.
Digestion|September 12, 2012
Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humansHanns-Ulrich Marschall, Martin Wagner, Gernot Zollner, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Digestive Diseases (Basel, Switzerland)|June 22, 2011
Targeting nuclear bile acid receptors for liver diseaseMichael Trauner, Anna Baghdasaryan, Thierry Claudel, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 23, 2018
Bile acids and glucocorticoid metabolism in health and diseaseVerena Theiler-Schwetz, Alex Zaufel, Hansjörg Schlager, et al.
Digestive Diseases (Basel, Switzerland)|June 22, 2011
Ursodeoxycholic acid for treatment of fatty liver disease and dyslipidemia in morbidly obese patientsHanns-Ulrich Marschall, Martin Wagner, Gernot Zollner, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 26, 2001
Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated miceGernot Zollner, Peter Fickert, Dagmar Silbert, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2007
Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosisGernot Zollner, Martin Wagner, Peter Fickert, et al.
Digestive Diseases (Basel, Switzerland)|May 13, 2010
New insights into autoimmune cholangitis through animal modelsMichael Trauner, Peter Fickert, Anna Baghdasaryan, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 22, 2017
Genetic loss of the muscarinic M<sub>3</sub> receptor markedly alters bile formation and cholestatic liver injury in miceFranziska Durchschein, Elisabeth Krones, Marion J Pollheimer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 23, 2005
Hepatobiliary transporter expression in human hepatocellular carcinomaGernot Zollner, Martin Wagner, Peter Fickert, et al.
BMC Gastroenterology|December 8, 2021
Hypercortisolism in patients with cholestasis is associated with disease severityVerena Theiler-Schwetz, Hansjörg Schlager, Barbara Obermayer-Pietsch, et al.
Digestion|September 12, 2012
Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humansHanns-Ulrich Marschall, Martin Wagner, Gernot Zollner, et al.
Pageof 7